NeoGenomics, Inc.
NEO
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytogenetics testing services to study normal and abnormalā¦ read more
Healthcare
Diagnostics & Research
21 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$11.90
Price+1.19%
$0.14
1Y
Price
Market Cap
$304m
Small
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.-5.3%
EBITDA Margin-14.4%
Net Profit Margin+0.3%
Free Cash Flow Margin-5.3%
EBITDA Margin-14.4%
Net Profit Margin+0.3%
Free Cash Flow MarginRevenue
$709.162m
+7.4%
1y CAGR+11.7%
3y CAGR+10.1%
5y CAGREarnings
-$113.468m
-44.1%
1y CAGR+1.8%
3y CAGR-405.7%
5y CAGREPS
-$4.40
-41.9%
1y CAGR+3.1%
3y CAGR-387.0%
5y CAGRBook Value
$838.290m
$1.375b
Assets$536.490m
Liabilities$410.308m
DebtDebt to Assets
29.9%
-10.2x
Debt to EBITDAFree Cash Flow
-$17.049m
+49.9%
1y CAGR+35.8%
3y CAGR+25.2%
5y CAGRNo items found.
Press Releases
Statements and updates from the company